Predictive Factors of Local Recurrence after Colorectal Cancer Liver Metastases Thermal Ablation
- PMID: 36976117
- PMCID: PMC10058972
- DOI: 10.3390/jimaging9030066
Predictive Factors of Local Recurrence after Colorectal Cancer Liver Metastases Thermal Ablation
Abstract
Background: Identify risk factors for local recurrence (LR) after radiofrequency (RFA) and microwave (MWA) thermoablations (TA) of colorectal cancer liver metastases (CCLM).
Methods: Uni- (Pearson's Chi2 test, Fisher's exact test, Wilcoxon test) and multivariate analyses (LASSO logistic regressions) of every patient treated with MWA or RFA (percutaneously and surgically) from January 2015 to April 2021 in Centre Georges François Leclerc in Dijon, France.
Results: Fifty-four patients were treated with TA for 177 CCLM (159 surgically, 18 percutaneously). LR rate was 17.5% of treated lesions. Univariate analyses by lesion showed factors associated with LR: sizes of the lesion (OR = 1.14), size of nearby vessel (OR = 1.27), treatment of a previous TA site LR (OR = 5.03), and non-ovoid TA site shape (OR = 4.25). Multivariate analyses showed that the size of the nearby vessel (OR = 1.17) and the lesion (OR = 1.09) remained significant risk factors of LR.
Conclusions: The size of lesions to treat and vessel proximity are LR risk factors that need to be considered when making the decision of thermoablative treatments. TA of an LR on a previous TA site should be reserved to specific situations, as there is an important risk of another LR. An additional TA procedure can be discussed when TA site shape is non-ovoid on control imaging, given the risk of LR.
Keywords: colorectal cancer; liver metastases; local recurrence; microwave; radiofrequency; thermoablation.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

References
-
- Imai K., Benitez C.C., Allard M.-A., Vibert E., Cunha A.S., Cherqui D., Castaing D., Bismuth H., Baba H., Adam R. Failure to Achieve a 2-Stage Hepatectomy for Colorectal Liver Metastases: How to Prevent It? Ann. Surg. 2015;262:772–778; discussion 778–779. doi: 10.1097/SLA.0000000000001449. - DOI - PubMed
-
- Ruers T., Van Coevorden F., Punt C.J.A., Pierie J.-P.E.N., Borel-Rinkes I., Ledermann J.A., Poston G., Bechstein W., Lentz M.-A., Mauer M., et al. Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial. J. Natl. Cancer Inst. 2017;109:djx015. doi: 10.1093/jnci/djx015. - DOI - PMC - PubMed
-
- de Baere T., Elias D., Dromain C., Din M.G., Kuoch V., Ducreux M., Boige V., Lassau N., Marteau V., Lasser P., et al. Radiofrequency Ablation of 100 Hepatic Metastases with a Mean Follow-up of More than 1 Year. AJR Am. J. Roentgenol. 2000;175:1619–1625. doi: 10.2214/ajr.175.6.1751619. - DOI - PubMed
-
- Solbiati L., Livraghi T., Goldberg S.N., Ierace T., Meloni F., Dellanoce M., Cova L., Halpern E.F., Gazelle G.S. Percutaneous Radio-Frequency Ablation of Hepatic Metastases from Colorectal Cancer: Long-Term Results in 117 Patients. Radiology. 2001;221:159–166. doi: 10.1148/radiol.2211001624. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous